Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry

  • Hiroki Kitakata
    Department of Cardiology Keio University School of Medicine Tokyo Japan
  • Takashi Kohno
    Department of Cardiology Keio University School of Medicine Tokyo Japan
  • Shun Kohsaka
    Department of Cardiology Keio University School of Medicine Tokyo Japan
  • Yasuyuki Shiraishi
    Department of Cardiology Keio University School of Medicine Tokyo Japan
  • Justin T. Parizo
    Division of Cardiovascular Medicine, Stanford University Stanford CA
  • Nozomi Niimi
    Department of Cardiology Keio University School of Medicine Tokyo Japan
  • Ayumi Goda
    Department of Cardiovascular Medicine Kyorin University School of Medicine Tokyo Japan
  • Yosuke Nishihata
    St Luke’s International Hospital Tokyo Japan
  • Paul A. Heidenreich
    Division of Cardiovascular Medicine, Stanford University Stanford CA
  • Tsutomu Yoshikawa
    Department of Cardiology Sakakibara Heart Institute Tokyo Japan

説明

<jats:sec xml:lang="en"> <jats:title>Background</jats:title> <jats:p xml:lang="en">Although 30‐day readmission is thought to be an important quality indicator in patients with hospitalized heart failure, its prognostic impact and comparison of patients who were readmitted beyond 30 days has not been investigated. We assessed early (0–30 days) versus midrange (31–90 days) readmission in terms of incidence and distribution, and elucidated whether the timing of readmission could have a different prognostic significance.</jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Methods and Results</jats:title> <jats:p xml:lang="en"> We examined patients with hospitalized heart failure registered in the <jats:styled-content style="fixed-case">WET</jats:styled-content> ‐ <jats:styled-content style="fixed-case">HF</jats:styled-content> (West Tokyo Heart Failure) registry. The primary outcomes analyzed were all‐cause death and <jats:styled-content style="fixed-case">HF</jats:styled-content> readmission. Data of 3592 consecutive patients with hospitalized heart failure (median follow‐up, 2.0 years [interquartile range, 0.8–3.1 years]; 39.6% women, mean age 73.9±13.3 years) were analyzed. Within 90 days after discharge, <jats:styled-content style="fixed-case">HF</jats:styled-content> readmissions occurred in 11.1% patients. Of them, patients readmitted within 30 and 31 to 90 days after discharge accounted for 43.1% and 56.9%, respectively. Independent predictors of 30‐ and 90‐day readmission were almost identical, and after adjustment, readmission for <jats:styled-content style="fixed-case">HF</jats:styled-content> within 90 days (including both early and midrange readmission) was an independent predictor of subsequent all‐cause death (hazard ratio, 2.36; <jats:italic>P</jats:italic> <0.001). Among 90‐day readmitted patients, the time interval from discharge to readmission was not significantly associated with subsequent all‐cause death. </jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Conclusions</jats:title> <jats:p xml:lang="en">Among patients readmitted within 90 days after index hospitalization discharge, ≈60% of readmission events occurred beyond 30 days. Patients readmitted within 90 days had a higher risk of long‐term mortality, regardless of the temporal proximity of readmission to the index hospitalization.</jats:p> </jats:sec>

収録刊行物

被引用文献 (10)*注記

もっと見る

参考文献 (35)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ